Plasmodium proteomics

parasite may identify novel drug and vaccine targets.

Written byJonathan Weitzman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the October 3 Nature, Laurence Florens and colleagues describe a large-scale proteomic study that complements the genome sequencing approach to understanding the malaria parasite Plasmodium falciparum (Nature, 419:520-526, October 3, 2002).

The Plasmodium life cycle is extremely complex, as the parasite must adapt to both vertebrate and invertebrate hosts, invade different cell types and evade the immune system. As a consequence of this, not all the stages of the parasite life cycle are amenable to cultivation and characterization in vitro.

Florens et al. analyzed the proteome isolated from different stages; sporozoites (the human infectious form), merozoites (the invasive stage), trophozoites (the form multiplying in erythrocytes) and gametocytes (sexual stages). Using multidimensional protein identification technology (MudPIT) they were able to detect about half of the predicted Plasmodium genes in the four stages — only 6% of proteins were common to all four stages.

The sporozoite proteome was very different from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo